These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 19100822)

  • 1. Mechanisms of drug release in citrate buffered HPMC matrices.
    Pygall SR; Kujawinski S; Timmins P; Melia CD
    Int J Pharm; 2009 Mar; 370(1-2):110-20. PubMed ID: 19100822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The suitability of tris(hydroxylmethyl) aminomethane (THAM) as a buffering system for hydroxypropyl methylcellulose (HPMC) hydrophilic matrices containing a weak acid drug.
    Pygall SR; Kujawinski S; Timmins P; Melia CD
    Int J Pharm; 2010 Mar; 387(1-2):93-102. PubMed ID: 20005935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing HPMC matrices with improved resistance to dissolved sugar.
    Williams HD; Ward R; Culy A; Hardy IJ; Melia CD
    Int J Pharm; 2010 Nov; 401(1-2):51-9. PubMed ID: 20858538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of polymer content on early gel-layer formation in HPMC matrices: The use of CLSM visualisation to identify the percolation threshold.
    Mason LM; Campiñez MD; Pygall SR; Burley JC; Gupta P; Storey DE; Caraballo I; Melia CD
    Eur J Pharm Biopharm; 2015 Aug; 94():485-92. PubMed ID: 26143369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
    Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
    Shoaib MH; Tazeen J; Merchant HA; Yousuf RI
    Pak J Pharm Sci; 2006 Apr; 19(2):119-24. PubMed ID: 16751122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Description of the release of sodium ferulate from hydroxypropyl methylcellulose based matrix tablets in vitro].
    Li FQ; Hu JH
    Yao Xue Xue Bao; 2004 May; 39(5):389-91. PubMed ID: 15338886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The extended release properties of HPMC matrices in the presence of dietary sugars.
    Williams HD; Ward R; Hardy IJ; Melia CD
    J Control Release; 2009 Sep; 138(3):251-9. PubMed ID: 19464331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrices containing NaCMC and HPMC 2. Swelling and release mechanism study.
    Conti S; Maggi L; Segale L; Ochoa Machiste E; Conte U; Grenier P; Vergnault G
    Int J Pharm; 2007 Mar; 333(1-2):143-51. PubMed ID: 17240091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of agitation sequence and ionic strength on in vitro drug release from hypromellose (E4M and K4M) ER matrices--the use of the USP III apparatus.
    Asare-Addo K; Kaialy W; Levina M; Rajabi-Siahboomi A; Ghori MU; Supuk E; Laity PR; Conway BR; Nokhodchi A
    Colloids Surf B Biointerfaces; 2013 Apr; 104():54-60. PubMed ID: 23298588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets.
    Zugasti ME; Zornoza A; Goñi Mdel M; Isasi JR; Vélaz I; Martín C; Sánchez M; Martínez-Ohárriz MC
    Drug Dev Ind Pharm; 2009 Oct; 35(10):1264-70. PubMed ID: 19555243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of micro-environmental pH on the gel layer behavior and release of a basic drug from various hydrophilic matrices.
    Varma MV; Kaushal AM; Garg S
    J Control Release; 2005 Mar; 103(2):499-510. PubMed ID: 15763629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel system for three-pulse drug release based on "tablets in capsule" device.
    Li B; Zhu J; Zheng C; Gong W
    Int J Pharm; 2008 Mar; 352(1-2):159-64. PubMed ID: 18055142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrices containing NaCMC and HPMC 1. Dissolution performance characterization.
    Conti S; Maggi L; Segale L; Ochoa Machiste E; Conte U; Grenier P; Vergnault G
    Int J Pharm; 2007 Mar; 333(1-2):136-42. PubMed ID: 17207943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the critical points of HPMC hydrophilic matrices for controlled drug delivery.
    Miranda A; Millán M; Caraballo I
    Int J Pharm; 2006 Mar; 311(1-2):75-81. PubMed ID: 16446063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of sodium dodecyl sulfate on swelling, erosion and release behavior of HPMC matrix tablets containing a poorly water-soluble drug.
    Zeng A; Yuan B; Fu Q; Wang C; Zhao G
    Pharm Dev Technol; 2009; 14(5):499-505. PubMed ID: 19743948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pH-independent drug release of an extremely poorly soluble weakly acidic drug from multiparticulate extended release formulations.
    Riis T; Bauer-Brandl A; Wagner T; Kranz H
    Eur J Pharm Biopharm; 2007 Jan; 65(1):78-84. PubMed ID: 16919924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Method to recover a lipophilic drug from hydroxypropyl methylcellulose matrix tablets.
    Williams RO; Sykora MA; Mahaguna V
    AAPS PharmSciTech; 2001 Jun; 2(2):E8. PubMed ID: 14727883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Swelling of hydroxypropyl methylcellulose matrix tablets. 2. Mechanistic study of the influence of formulation variables on matrix performance and drug release.
    Gao P; Skoug JW; Nixon PR; Ju TR; Stemm NL; Sung KC
    J Pharm Sci; 1996 Jul; 85(7):732-40. PubMed ID: 8818998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.